» Articles » PMID: 24795093

Platelet-rich Plasma: Applications in Dermatology

Overview
Specialty Dermatology
Date 2014 May 6
PMID 24795093
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, the use of platelet-rich plasma has increased notably in a range of diseases and settings. Uses of these products now go beyond skin rejuvenation therapy in patients with facial ageing. Good outcomes for other dermatological indications such as skin ulcers and, more recently, alopecia have been reported in case series and controlled studies. However, these indications are not currently included in the labeling given that stronger scientific evidence is required to support their real benefits. With the increased use of these products, dermatologists need to become familiar with the underlying biological principles and able to critically assess the quality and outcomes of the studies of these products in different skin diseases.

Citing Articles

Platelet rich plasma and anterior cruciate ligament repair: A new frontier, or a short term adjunct.

Gill S, Cenci G, Falcinelli S, Marzano F, Carriero B, Filippi N World J Orthop. 2025; 16(1):100693.

PMID: 39850039 PMC: 11752475. DOI: 10.5312/wjo.v16.i1.100693.


Therapeutic potential of platelet rich plasma against experimental infection: in vivo study in immunosuppressed mice.

Mahmoud N, Younis A, Zalat R, Soliman A, Khater M J Parasit Dis. 2024; 48(4):849-859.

PMID: 39493467 PMC: 11528079. DOI: 10.1007/s12639-024-01713-y.


Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarring.

Gaumond S, Abdin R, Yaghi M, Mahmoud R, Rodriguez M, Eber A Lasers Med Sci. 2024; 39(1):254.

PMID: 39387947 PMC: 11467096. DOI: 10.1007/s10103-024-04192-y.


Comparison of the Effectiveness of Platelet-Rich Plasma Versus Tranexamic Acid Plus Vitamin C Mesotherapy in the Treatment of Periorbital Hyperpigmentation: A Split-Site, Randomized Clinical Trial.

Iranmanesh B, Rastaghi F, Hashemi N, Kaveh R J Cosmet Dermatol. 2024; 23(12):4066-4071.

PMID: 39279329 PMC: 11626328. DOI: 10.1111/jocd.16548.


Adverse events related to platelet-rich plasma therapy and future issues to be resolved.

Arita A, Tobita M Regen Ther. 2024; 26:496-501.

PMID: 39100535 PMC: 11295534. DOI: 10.1016/j.reth.2024.07.004.